Kaer Biotherapeutics
Escondido, CA
- UEI
- J6MVM8F3HM25
- CAGE
- 5JHC0
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 926 S Andreasen Dr #10, Escondido, CA 92029, USA
- Website
- kaerbio.com
- Founded
- 2008
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Supraer-CA model 3 | Medical Command (Army) | $65,507 |
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Non-invasive surfactant aerosol therapy for RDS | National Heart Lung and Blood Institute (NIH) | $299,719 | |
| Aerosol delivery of surfactant for ards | National Heart Lung and Blood Institute (NIH) | $1,766,361 | |
| Aerosol delivery of surfactant for ards | National Institutes of Health | $290,883 |
Quick answers
Is Kaer Biotherapeutics registered in SAM.gov?
Yes. Kaer Biotherapeutics's SAM.gov registration is active through December 18, 2026.
What is Kaer Biotherapeutics's most recent federal award?
Kaer Biotherapeutics's most recent federal grant award is Non-invasive surfactant aerosol therapy for RDS (R43HL142335), from National Heart Lung and Blood Institute (NIH), on February 15, 2019.
On GovTribe
See Kaer Biotherapeutics's full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors